squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• RTX-224 Monotherapy in Patients With Solid Tumors#852137ClinicalTrials.gov
• Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides#874538ClinicalTrials.gov
• Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer#811306ClinicalTrials.gov
• Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients#886523ClinicalTrials.gov
• FACE-Q in Facial Reconstructive Surgery: A Prospective Database#843393ClinicalTrials.gov
• Trop2-targeting NIR-II Molecular Probe for Precision Diagnosis of Oral Cancer#861152ClinicalTrials.gov
• Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer#121336ClinicalTrials.gov
• Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC#261523ClinicalTrials.gov
• ACOT9, a mitochondrial metabolism-related gene, promotes ROS-associated epithelial remodeling in laryngeal squamous cell carcinoma.#375323NCBI PubMed Central
• Mapping immune activity in HPV-negative head and neck squamous cell carcinoma: a spatial multiomics analysis#388158HAL (France)
• Biomarker-based Study in R/M SCCHN#405150ClinicalTrials.gov
• Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma#810182ClinicalTrials.gov
• Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial#826466ClinicalTrials.gov
• Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC#842925ClinicalTrials.gov
• Temporally Feathered Radiation Therapy (TFRT) for Head and Neck Squamous Cell Carcinoma#873094ClinicalTrials.gov
• p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)#875496ClinicalTrials.gov
• Sleep and Circadian Rhythm Study in Head and Neck Cancer Patients#880947ClinicalTrials.gov
• Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)#888221ClinicalTrials.gov
• The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial#158165ClinicalTrials.gov
• Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer#826572ClinicalTrials.gov
• Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients#877024ClinicalTrials.gov
• Data Sheet 7_Analysis of 16S rRNA to evaluate taxonomic differences between salivary and intratumoral microbiota in patients affected by oral squamous cell carcinoma: a single-center pilot study.csv#395105Figshare
• A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma#849539ClinicalTrials.gov
• Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)#889614ClinicalTrials.gov
• Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer#201782ClinicalTrials.gov
• Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic#844615ClinicalTrials.gov
• Detecting HPV DNA in Anal and Cervical Cancers#859937ClinicalTrials.gov
• Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC#877179ClinicalTrials.gov
• A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)#866337ClinicalTrials.gov
• Bone marrow mesenchymal stem cell-derived exosomal miR-93-5p suppresses esophageal squamous cell carcinoma progression and immune escape through targeting PD-L1.#685690NCBI PubMed Central
• Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer#899333ClinicalTrials.gov
• CISH Inactivated TILs in the Treatment of NSCLC#628523ClinicalTrials.gov
• Skin Cancer and Hyperthermia and Radiotherapy#828071ClinicalTrials.gov
• Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions#871428ClinicalTrials.gov
• Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck#838031ClinicalTrials.gov
• TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers#890580ClinicalTrials.gov
• Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma#825820ClinicalTrials.gov
• Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer#245492ClinicalTrials.gov
• Aspartate Aminotransferase/Alanine Aminotransferase Ratio Predicts the Post-surgical Prognosis of Patients with Oral Squamous Cell Carcinoma.#3941NCBI PubMed Central
• Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck#121357ClinicalTrials.gov
• Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)#142519HAL (France)
• Heterogeneous Sensitivity to Src Inhibitors in Oral Squamous Cell Carcinoma and Its Implications for Combination Therapy with Cisplatin#162263bioRxiv / medRxiv
• EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC#162450ClinicalTrials.gov
• Prognosis and risk factors for pathological non-response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma.#182482NCBI PubMed Central
• Multi-omics investigation of perineural invasion in head and neck squamous cell carcinoma: neuroimmune mechanisms and clinical implications.#236117NCBI PubMed Central
• Flow-cytometric profiling of large extracellular vesicles as immunophenotypic biomarkers in head and neck squamous cell carcinoma.#244239NCBI PubMed Central
• Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy#249619ClinicalTrials.gov
• DKK1 and CKAP4 expression is associated with cervical lymph node metastasis in tongue squamous cell carcinoma#321471bioRxiv / medRxiv
• Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma#349941ClinicalTrials.gov
• Leptomeningeal carcinomatosis in a patient with recurrent unresectable squamous cell carcinoma of the retromolar trigone—a brief report#376096PubMed Central